More in specialty pharmacy mail order (From Pharmacy Best Practices, Dec. 2007)
Groups such as WellPoint are turning specialty pharmacy into a highly beneficial business model for everyone from the non-clinician to physicians.
Groups such as WellPoint are turning specialty pharmacy into a highly beneficial business model for everyone from the non-clinician to physicians.
WellPoint offers specialty pharmacy through PrecisionRx Specialty Solutions, which has a new state-of-the-art facility in Indianapolis that handles more than 1,000 drugs for 14 diseases, including hemophilia, multiple sclerosis, rheumatoid arthritis, psoriasis, Hepatitis C and cancer.
The new facility uses much of the same technology for specialty pharmacy as it employs to mail order, but also has implemented automated dispensing of large refrigerated boxes containing many of the specialty drugs. "Freeing up personnel enables us to shift resources from fulfillment to care management," says Matt Totterdale, staff vice president, PrecisionRx Pharmacy Operations.
Totterdale points out that patients using mail service are older than most availing themselves of specialty pharmacy, thus, opening up modes of communication, such as cell phones and computers, for the latter.
In addition to the monthly calls, clinicians conduct risk assessments, stratify patients, contact them and again determine next steps, which may include outreach to the member's physician. Issues such as non-compliance and hospitalization are two areas of concern. "We advocate for our patients," Totterdale adds. Results of these care management programs are not yet available.
Totterdale says that self-injected drugs sent to patients' homes far outweigh the office-infused or office-injectables, but he foresees that with the advent of some new biologics, the balance will fall more toward 50/50 between home- and office-based delivery.
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen
Upended: Can PBM Transparency Succeed?
March 6th 2024Simmering tensions in the pharmacy benefit management (PBM) industry have turned into fault lines. The PBMs challenging the "big three" have formed a trade association. Purchaser coalitions want change. The head of the industry's trade group says inherent marketplace friction has spilled over into political friction.
Read More
Briana Contreras, editor of Managed Healthcare Executive, spoke with Nancy Lurker, CEO and president of EyePoint Pharmaceuticals. Nancy shared a bit about EyePoint and how the organization’s innovative therapies are addressing patient needs through eye care, and most importantly, she addressed C-Suite positions like the CEO role. Nancy shared advice for those seeking to reach the CEO level, especially toward women in healthcare and other roles, and what it takes to run a biopharma company.
Listen
The deliberate disconnection of Change Healthcare to ring fence a cyberattack entered its seventh day today. Prescribers are finding ways to get pharmacy claims processed, and UnitedHealth Group says disruption to the dispensing of prescriptions has been minimal. But independent pharmacies want more information and protection from financial consequences from pharmacy benefit managers.
Read More
